A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons

Cell Death and Disease

Volumn 4, Issue 6, 2013, Pages

  Fujiki, R ^a,b   Sato, A ^a,b   Fujitani, M ^a,b   Yamashita, T ^a,b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

apoptosis; ES derived glutamatergic neuron; histone acetylation; neural progenitor cell; valproic acid

Indexed keywords

GLUTAMIC ACID; HISTONE DEACETYLASE; HISTONE H3; VALPROIC ACID; VALPROMIDE;

APOPTOSIS; ARTICLE; BRAIN CELL; CELL POPULATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; EMBRYONIC STEM CELL; ENZYME INHIBITION; HISTONE ACETYLATION; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; PROGENY; PYRAMIDAL NERVE CELL; WESTERN BLOTTING;

EID: 84879677708     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.205     Document Type: Article

References (38)

1. Henry TR. The history of valproate in clinical neuroscience. Psychopharmacol Bull 2003; 37: 5-16.
2. Kwan P, Sills GJ, Brodie MJ. The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Ther 2001; 1: 21-34.
3. Gould TD, Quiroz JA, Singh J, Zarate CA, Manji HK. Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers. Mol Psychiatry 2004; 8: 734-755.
4. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazer MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001; 276: 36734-36741.
5. Kazantsev AG, Thompson LM. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nat Rev Drug Discov 2008; 7: 854-868.
6. Gö ttlicher M, Minucci S, Zhu P, Krämer OH, Schimpf A, Giavara S et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001; 20: 6969-6978.
7. Gurvich N, Tsygankova OM, Meinkoth JL, Klein PS. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res 2004; 64: 1079-1086.
8. Shabbeer S, Kortenhorst MS, Kachhap S, Galloway N, Rodriguez R, Carducci MA et al. Multiple molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo. Prostate 2007; 67: 1099-1110.
9. Blaheta RA, Cinatl Jr J. Anti-tumor mechanisms of valproate: a novel role for an old drug. Med Res Rev 2002; 22: 492-511.
10. Hrebackova J, Hrabeta J, Eckschlager T. Valproic acid in the complex therapy of malignant tumors. Curr Drug Targets 2010; 11: 361-379.
11. Phillips A, Bullock T, Plant N. Sodium valproate induces apoptosis in the rat hepatoma cell line, FaO. Toxicology 2003; 192: 219-227.
12. Krämer OH, Knauer SK, Zimmermann D, Stauber RH, Heinzel T. Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis. Oncogene 2008; 27: 732-740.
13. Krämer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA et al. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 2003; 22: 3411-3420.
14. Detich N, Bovenzi V, Szyf M. Valproate induces replication-independent active DNA demethylation. J Biol Chem 2003; 278: 27586-27592.
15. Eadie MJ. Antiepileptic drugs as human teratogens. Expert Opin Drug Saf 2008; 7: 195-209.
16. Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C. Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 2008; 81: 1-13.
17. Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK et al. Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 2010; 362: 2185-2193.
18. Downing C, Biers J, Larson C, Kimball A, Wright H, Ishii T et al. Genetic and maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice. Toxicol Sci 2010; 116: 632-639.
19. Tung EW, Winn LM. Epigenetic modifications in valproic acid-induced teratogenesis. Toxicol Appl Pharmocol 2010; 248: 201-209.
20. Coyle JT, Duman RS. Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 2003; 38: 157-160.
21. Bielecka AM, Obuchowicz E. Antiapoptotic action of lithium and valproate. Pharmacol Rep 2008; 60: 771-782.
22. Yasuda S, Liang MH, Marinova Z, Yahyavi A, Chuang DM. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 2009; 14: 51-59.
23. Jeong MR, Hashimoto R, Senatorov VV, Fujimaki K, Ren M, Lee MS et al. Valproic acid, a mood stabilizer and anticonvulsant, protects rat cerebral cortical neurons from spontaneous cell death: a role of histone deacetylase inhibition. FEBS Lett 2003; 542: 74-78.
24. Jung GA, Yoon JY, Moon BS, Yang DH, Kim HY, Lee SH et al. Valproic acid induces differentiation and inhibition of proliferation in neural progenitor cells via the beta-catenin-Ras-ERK-p21Cip/WAF1 pathway. BMC Cell Biol 2008; 9: 66.
25. Laeng P, Pitts RL, Lemire AL, Drabik CE, Weiner A, Tang H et al. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells. J Neurochem 2004; 91: 238-251.
26. Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH. Histone deacetylase inhibitionmediated neuronal differentiation of multipotent adult neural progenitor cells. Proc Natl Acad Sci USA 2004; 101: 16659-16664.
27. Abematsu M, Tsujimura K, Yamano M, Saito M, Kohno K, Kohyama J et al. Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. J Clin Invest 2010; 120: 3255-3266.
28. Go HS, Seo JE, Kim KC, Han SM, Kim P, Kang YS et al. Valproic acid inhibits neural progenitor cell death by activation of NF-kB signaling pathway and up-regulation of Bcl-XL. J Biomed Sci 2011; 18: 48.
29. Salminen A, Tapiola T, Korhonen P, Suuronen T. Neuronal apoptosis induced by histone deacetylase inhibitors. Brain Res Mol Brain Res 1998; 61: 203-206.
30. Boutillier AL, Trinh E, Loeffler JP. Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis. J Neurochem 2003; 84: 814-828.
31. Ikonomidou C, Turski L. Antiepileptic drugs and brain development. Epilepsy Res 2010; 88: 11-22.
32. Kataoka S, Takuma K, Hara Y, Maeda Y, Ago Y, Matsuda T. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int J Neuropsychopharamocol 2011; 18: 1-13.
33. Bibel M, Richter J, Schrenk K, Tucker KL, Staiger V, Korte M et al. Differentiation of mouse embryonic stem cells into a defined neuronal lineage. Nat Neurosci 2004; 7: 1003-1009.
34. Bibel M, Richter J, Lacroix E, Barde YA. Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells. Nat Protoc 2007; 2: 1034-1043.
35. Chatzi C, Scott RH, Pu J, Lang B, Nakamoto C, McCaig CD et al. Derivation of homogeneous GABAergic neurons from mouse embryonic stem cells. Exp Neurol 2009; 217: 407-416.
36. Spiliotopoulos D, Goffredo D, Conti L, Di Febo F, Biella G, Toselli M et al. An optimized experimental strategy for efficient conversion of embryonic stem (ES)-derived mouse neural stem (NS) cells into a nearly homogeneous mature neuronal population. Neurobiol Dis 2009; 34: 320-331.
37. Fujiki R, Sato A, Hata K, Tashiro F, Yasuhara N, Miyazaki J et al. Improvement in protocol to generate of homogeneous glutamatergic neurons from mouse embryonic stem cells reduced apoptosis. Biochem Biophys Res Commun 2013; 430: 604-609.
38. Marks PA, Richon VM, Rifkind RA. Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 2000; 92: 1210-1216.